MAPKAPK3 was co-expressed with TSPO in glioma tissues, whereas suppression of TSPO inhibited the expression of MAPKAPK3 in U251 and U87 cells and increased its mRNA degradation. Here, MAPKAPK3 is linked to central nervous system cancer.